IRS1 and diabetes mellitus: Once the effects of Axl on glucose uptake and/or glucose metabolism are established, novel strategies may be devised to target the molecules involved in these pathways, e.g., TNS2 and IRS-1, to improve the treatment for PDAC and diabetes.